Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03452956 · ClinicalTrials.gov registry record
Cognitive Impairement In Frontotemporal Dementia
A clinical trial, sponsored by University of Pennsylvania.
- Completed
- Registry status
- 997
- Enrollment target
NCT03452956: Completed study, sponsored by University of Pennsylvania.
NCT03452956 is a clinical trial that has completed, run by University of Pennsylvania. The registered enrollment target is 997 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03452956 has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- 997 participants
- Enrollment target
Study Summary
This is an observational study that aims to better understand the genetic causes of frontotemporal degeneration (FTD), Multiple Systems Atrophy (MSA), and Progressive Supranuclear Palsy (PSP). It is hoped the information gathered in this study will help lead to better diagnostics and future treatments.
Interventions
- OTHER None-Observation Only
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 997 participants |
| Start Date | 2003-07-01 |
| Est. Completion | 2020-07-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03452956
The ClinicalTrials.gov registry entry for NCT03452956 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 997 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which None-Observation Only is the first listed.
NCT03452956 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03452956 about?
NCT03452956 is a clinical study titled "Cognitive Impairement In Frontotemporal Dementia". This is an observational study that aims to better understand the genetic causes of frontotemporal degeneration (FTD), Multiple Systems Atrophy (MSA), and Progressive Supranuclear Palsy (PSP). It is hoped the information gathered in this study will help lead to better diagnostics and future treatmen...
What is the current status of trial NCT03452956?
This trial is currently completed. The enrollment target is 997 participants. The study started on 2003-07-01. Estimated completion is 2020-07-15.
What interventions are being tested in trial NCT03452956?
The interventions under investigation include: None-Observation Only (OTHER).
Who is sponsoring clinical trial NCT03452956?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.